Herbal mix shows promise in COVID fight, but more research needed
NCT ID NCT05043324
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 29 times
Summary
This study tested a herbal supplement called AntiCov-220 in 82 adults with high-risk conditions like HIV or cancer. The goal was to see if it could safely prevent or treat COVID-19 by boosting the immune system and fighting the virus. The results focused on safety, with a few cases showing no severe changes, but the study was small and completed without strong proof of effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Saigon Biopharma Company Limited
Ho Chi Minh City, 700000, Vietnam
-
Saigon Biopharma LLC
Wilmington, Delaware, 19801-6601, United States
Conditions
Explore the condition pages connected to this study.